207 related articles for article (PubMed ID: 29724991)
1. HOXB9 promotes endometrial cancer progression by targeting E2F3.
Wan J; Liu H; Feng Q; Liu J; Ming L
Cell Death Dis; 2018 May; 9(5):509. PubMed ID: 29724991
[TBL] [Abstract][Full Text] [Related]
2. High expression of transcriptional factor HoxB9 predicts poor prognosis in patients with lung adenocarcinoma.
Zhan J; Wang P; Niu M; Wang Y; Zhu X; Guo Y; Zhang H
Histopathology; 2015 Jun; 66(7):955-65. PubMed ID: 25324169
[TBL] [Abstract][Full Text] [Related]
3. PCAF-mediated acetylation of transcriptional factor HOXB9 suppresses lung adenocarcinoma progression by targeting oncogenic protein JMJD6.
Wan J; Xu W; Zhan J; Ma J; Li X; Xie Y; Wang J; Zhu WG; Luo J; Zhang H
Nucleic Acids Res; 2016 Dec; 44(22):10662-10675. PubMed ID: 27613418
[TBL] [Abstract][Full Text] [Related]
4. Elevated HOXB9 expression promotes differentiation and predicts a favourable outcome in colon adenocarcinoma patients.
Zhan J; Niu M; Wang P; Zhu X; Li S; Song J; He H; Wang Y; Xue L; Fang W; Zhang H
Br J Cancer; 2014 Aug; 111(5):883-93. PubMed ID: 25025961
[TBL] [Abstract][Full Text] [Related]
5. BMI‑1 promotes invasion and metastasis in endometrial adenocarcinoma and is a poor prognostic factor.
Yu J; Chen L; Bao Z; Liu Y; Liu G; Li F; Li L
Oncol Rep; 2020 May; 43(5):1630-1640. PubMed ID: 32323819
[TBL] [Abstract][Full Text] [Related]
6. HOXB9 expression promoting tumor cell proliferation and angiogenesis is associated with clinical outcomes in breast cancer patients.
Seki H; Hayashida T; Jinno H; Hirose S; Sakata M; Takahashi M; Maheswaran S; Mukai M; Kitagawa Y
Ann Surg Oncol; 2012 Jun; 19(6):1831-40. PubMed ID: 22396001
[TBL] [Abstract][Full Text] [Related]
7. HOXB9 promotes epithelial-to-mesenchymal transition via transforming growth factor-β1 pathway in hepatocellular carcinoma cells.
Sha L; Dong L; Lv L; Bai L; Ji X
Clin Exp Med; 2015 Feb; 15(1):55-64. PubMed ID: 25081022
[TBL] [Abstract][Full Text] [Related]
8. Bevacizumab terminates homeobox B9-induced tumor proliferation by silencing microenvironmental communication.
Hoshino Y; Hayashida T; Hirata A; Takahashi H; Chiba N; Ohmura M; Wakui M; Jinno H; Hasegawa H; Maheswaran S; Suematsu M; Kitagawa Y
Mol Cancer; 2014 May; 13():102. PubMed ID: 24885802
[TBL] [Abstract][Full Text] [Related]
9. Homeobox B9 Promotes Colon Cancer Progression by Targeting SRSF3.
Yuan L; Cheng F; Wu Z; Li X; Shen W
Dig Dis Sci; 2023 Aug; 68(8):3324-3340. PubMed ID: 37258980
[TBL] [Abstract][Full Text] [Related]
10. QKI-6 inhibits bladder cancer malignant behaviours through down-regulating E2F3 and NF-κB signalling.
Shi F; Deng Z; Zhou Z; Jiang CY; Zhao RZ; Sun F; Cui D; Bei XY; Yang BY; Sun Q; Wang XJ; Wu Q; Xia SJ; Han BM
J Cell Mol Med; 2019 Oct; 23(10):6578-6594. PubMed ID: 31449345
[TBL] [Abstract][Full Text] [Related]
11. Identification of HOXB9 to predict prognosis of endometrial cancer based on comprehensive bioinformatics analysis.
Xu Y; Zhang M; Shi Q; Cheng X; Du R; Li C; Zhang Y
Eur J Med Res; 2023 Feb; 28(1):79. PubMed ID: 36803556
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of BP1, an isoform of Homeobox Gene DLX4, promotes cell proliferation, migration and predicts poor prognosis in endometrial cancer.
Zhang L; Wan Y; Jiang Y; Zhang Z; Shu S; Cheng W; Lang J
Gene; 2019 Jul; 707():216-223. PubMed ID: 31100338
[TBL] [Abstract][Full Text] [Related]
13. GalNAc-T14 promotes metastasis through Wnt dependent HOXB9 expression in lung adenocarcinoma.
Kwon OS; Oh E; Park JR; Lee JS; Bae GY; Koo JH; Kim H; Choi YL; Choi YS; Kim J; Cha HJ
Oncotarget; 2015 Dec; 6(39):41916-28. PubMed ID: 26544896
[TBL] [Abstract][Full Text] [Related]
14. Silencing of HOXB9 suppresses cellular proliferation, angiogenesis, migration and invasion of prostate cancer cells.
Xu H; Wu S; Shen X; Wu D; Qin Z; Wang H; Chen X; Sun X
J Biosci; 2020; 45():. PubMed ID: 32098919
[TBL] [Abstract][Full Text] [Related]
15.
Martinou E; Moller-Levet C; Karamanis D; Bagwan I; Angelidi AM
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216396
[TBL] [Abstract][Full Text] [Related]
16. An E2F1-HOXB9 transcriptional circuit is associated with breast cancer progression.
Zhussupova A; Hayashida T; Takahashi M; Miyao K; Okazaki H; Jinno H; Kitagawa Y
PLoS One; 2014; 9(8):e105285. PubMed ID: 25136922
[TBL] [Abstract][Full Text] [Related]
17. The role of HOXB9 and miR-196a in head and neck squamous cell carcinoma.
Darda L; Hakami F; Morgan R; Murdoch C; Lambert DW; Hunter KD
PLoS One; 2015; 10(4):e0122285. PubMed ID: 25860510
[TBL] [Abstract][Full Text] [Related]
18. Fibrinogen‑like‑protein 1 promotes the invasion and metastasis of gastric cancer and is associated with poor prognosis.
Zhang Y; Qiao HX; Zhou YT; Hong L; Chen JH
Mol Med Rep; 2018 Aug; 18(2):1465-1472. PubMed ID: 29845203
[TBL] [Abstract][Full Text] [Related]
19. HOXB9 Expression Correlates with Histological Grade and Prognosis in LSCC.
Sun C; Han C; Wang P; Jin Y; Sun Y; Qu L
Biomed Res Int; 2017; 2017():3680305. PubMed ID: 28808656
[TBL] [Abstract][Full Text] [Related]
20. Decreased carbonyl reductase 1 expression promotes malignant behaviours by induction of epithelial mesenchymal transition and its clinical significance.
Murakami A; Yakabe K; Yoshidomi K; Sueoka K; Nawata S; Yokoyama Y; Tsuchida S; Al-Mulla F; Sugino N
Cancer Lett; 2012 Oct; 323(1):69-76. PubMed ID: 22542806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]